302
Views
42
CrossRef citations to date
0
Altmetric
Articles

Neovascularization by bFGF releasing hyaluronic acid–gelatin microspheres: in vitro and in vivo studies

, &
Pages 426-436 | Received 09 May 2010, Accepted 12 Jul 2010, Published online: 21 Sep 2010

References

  • Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer C, Kastenbauer E, Naumann A. 1998. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res. 42:172–181.
  • Balazs EA, Laurent TC, Jeanloz RW. 1986. Nomenclature of hyaluronic acid. Biochem J. 235:903.
  • Cheresh D, editors. 2008. Angiogenesis: in vitro systems Methods in enzymology. San Diego: Academic Press, Elsevier. p 443–452.
  • Chung HJ, Kim HK, Yoon JJ, Park TG. 2006. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res. 23 8: 1835–1841.
  • Collins MN, Birkinshaw C. 2008. Investigation of swelling behaviour of crosslinked hyaluronic acid films and hyrdogels produced using homogeneous reactions. J Appl Polym Sci. 109:923–931.
  • Cortesi R, Nastruzzi C, Davis SS. 1998. Sugar-crosslinked gelatin for controlled release: Microspheres and discs. Biomaterials. 19:1641–1649.
  • Elcin YM, Akbulut U. 1992. Polyester film strips coated with photographic gelatin containing immobilized glucose-oxidase hardened by chromium (III) sulfate. Biomaterials. 13 3: 156–161.
  • Elcin AE, Elcin YM. 2006. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. Tissue Eng. 12 4: 959–968.
  • Elcin YM, Cokmus C, Sacilik SC. 1995. Aluminum carboxymethylcellulose encapsulation of B. sphaericus-2362 for control of Culex spp larvae. J Econ Entomol. 88 4: 830–834.
  • Elcin YM, Dixit V, Gitnick G. 1996. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres and fibers for localized angiogenesis: in vitro and in vivo studies. Artif Cell Blood Sub. 24 3: 257–271.
  • Elcin YM, Dixit V, Gitnick G. 1998. Hepatocyte attachment on biodegradable modified chitosan membranes: in vitro evaluation for the development of liver organoids. Artif Organs. 22 10: 837–846.
  • Elcin YM, Dixit V, Lewin K, Gitnick G. 1999. Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach. Artif Organs. 23 2: 146–152.
  • Elcin YM, Dixit V, Gitnick G. 2001. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: Implications for tissue engineering and wound healing. Artif Organs. 25 7: 558–565.
  • Elcin YM, Elcin AE, Pappas GD. 2003. Functional and morphological characteristics of bovine adrenal chromaffin cells on macroporous poly (DL-lactide-co-glycolide) scaffolds. Tissue Eng. 9 5: 1047–1056.
  • Esposito E, Menegatti E, Cortesi R. 2005. Hyaluronan-based microspheres as tools for drug delivery: A comparative study. Int J Pharm. 288:35–49.
  • Fannon M, Forsten KE, Nugent MA. 2000. Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response. Biochemistry. 39 6: 1434–1445.
  • Folkman J. 1971. Tumor angiogenesis: Therapeutic implications. New Engl J Med. 285:1182–1186.
  • Gospodarowicz D. 1974. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 249:123–127.
  • Heatley F, Scott JE. 1988. A water molecule participates in the secondary structure of hyaluronan. Biochem J. 254:489–493.
  • Ikada Y, Tabata Y. 1998. Protein release from gelatin matrices. Adv Drug Deliv Rev. 31:287–301.
  • Inanc B, Elcin AE, Koc A, Balos K, Parlar A, Elcin YM. 2007. Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. J Biomed Mater Res A. 82A 4: 917–926.
  • Kluge T, Masuda A, Yamashita K, Ushida K. 1998. Effects of charge and structure of hyaluronic acid on the luminescence quenching in aqueous solution. J Photochem Photobiol A. 68 5: 771–775.
  • Leach JB, Bivens KA, Patrick CWJr, Schmidt CE. 2003. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng. 82:578–589.
  • Lee H, Cusick RA, Browne F, Ho KT, Ma PX, Utsunomiya H, Langer R, Vacanti JP. 2002. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation. 73 10: 1589–1593.
  • Liang HC, Chang WH, Liang HF, Lee MH, Sung HW. 2004. Crosslinking structures of gelatin hydrogels crosslinked with genipin or a water-soluble carbodiimide. J Appl Polym Sci. 91:4017–4026.
  • Lim ST, Martin GP, Berry DJ, Brown MB. 2000. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release. 66:281–292.
  • Luo Y, Kirker KR, Prestwich GD. 2009. Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J Control Release. 69:169–184.
  • Masters KS, Shah DN, Leinwand LA, Anseth KS. 2005. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials. 26:2517–2525.
  • Nazzal S, Wang Y. 2001. Characterization of soft gelatin capsules by thermal analysis. Int J Pharm. 230:35–45.
  • Ogawa K, Asonuma K, Inamoto Y, Tabata Y, Tanaka K. 2001. The efficacy of prevascularization by basic FGF for hepatocyte transplantation using polymer devices in rats. Cell Transplant. 10:723–729.
  • Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD. 2004. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials. 25 14: 2789–2798.
  • Peattie RA, Pike DB, Yu B, Cai S, Shu XZ, Prestwich GD, Firpo MA, Fisher RJ. 2008. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv. 15 6: 389–397.
  • Pieper JS, Hafmans T, van Wachem PB, van Luyn MJ, Brouwer LA, Veerkamp JH, van Kuppevelt TH. 2002. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res. 62 2: 185–194.
  • Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. 1998. Controlled chemical modification of hyaluronic acid: Synthesis, applications and biodegradation of hydrazide derivatives. J Control Release. 53:93–103.
  • Schwendeman SP, Cardamone M, Brandon MR, Klibanov A, Langer R. 1996. Stability of proteins and their delivery from biodegradable polymer microspheres. In: Cohen S, Bernstein H. editors. Microspheres/microparticles-characterization and pharmaceutical application. New York: Marcel Dekker Inc. p 1–49.
  • Tabata Y, Nagano A, Muniruzzaman M, Ikada Y. 1998. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials. 19 19: 1781–1789.
  • Tayalia P, Mooney DJ. 2009. Controlled growth factor delivery for tissue engineering. Adv Mater. 21 32-33: 3269–3285.
  • Tomihata K, Ikada Y. 1997. Crosslinking of hyaluronic acid with water-soluble carbodiimide. J Biomed Mater Res. 37:243–251.
  • Tomihata K, Ikada Y. 2000. Crosslinking of hyaluronic acid with glutaraldehyde. J Polym Sci Pol Chem. 35:3553–3559.
  • Vandelli MA, Rivasi F, Guerra P, Forni F, Arletti R. 2001. Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: Preparation, characterization, in vitro and in vivo studies. Int J Pharm. 215:175–184.
  • Wagner WR, Guan J, Stankus JJ. 2007. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release. 120:70–78.
  • Wieland JA, Houchin-Ray TL, Shea LD. 2007. Non-viral vector delivery from PEG-hyaluronic acid hyrdogels. J Control Release. 120:233–241.
  • Wilcke I, Lohmeyer JA, Liu S, Condurache A, Krüger S, Mailänder P, Machens HG. 2007. VEGF165 and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbeck Arch Surg. 392:305–314.
  • Wissink MJB, Beernink R, Poot AA, Engbers GHM, Beugeling T, van Aken WG, Feijen J. 2000. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release. 64:103–114.
  • Young S, Wong M, Tabata Y, Mikos AG. 2005. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release. 109:256–274.
  • Yun YH, Goertz DJ, Yellen P, Chen W. 2004. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials. 25:147–157.
  • Zhao F, Grayson WL, Ma T, Bunnell B, Lu WW. 2006. Effects of hydroxyapatite in 3D chitosan-gelatin polymer network on human mesenchymal stem cell contruct development. Biomaterials. 27:1859–1867.
  • Zhu X, Komiya H, Chirino A, Faham S, Fox GM, Arakawa T, Hsu BT, Rees DC. 1991. Three-dimensional structures of acidic and basic fibroblast growth factors. Science. 251 4989: 90–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.